Treatment With hOKT3gamma1(Ala-Ala) in T1DM

Clinical trial NCT00806572 · TERMINATED

Trial details

NCT number: NCT00806572
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1

Start date: 2002-05-01
Primary completion: 2004-07-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.